No Data
No Data
Express News | IDEAYA Biosciences Inc : Wedbush Cuts Target Price to $54 From $56
Wedbush Cuts Price Target on IDEAYA Biosciences to $54 From $56, Maintains Outperform Rating
IDEAYA Biosciences (IDYA) has an average buy rating and price target range of $46 to $69, according to analysts polled by Capital IQ.Price: 43.05, Change: +1.70, Percent Change: +4.11
Industry Analysts Just Made A Meaningful Upgrade To Their IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Revenue Forecasts
IDEAYA Biosciences Is Maintained at Overweight by JP Morgan
IDEAYA Biosciences Is Maintained at Overweight by JP
JPMorgan Raises Price Target on IDEAYA Biosciences to $69 From $65, Maintains Overweight Rating
IDEAYA Biosciences (IDYA) has an average buy rating and price target range of $46 to $69, according to analysts polled by Capital IQ.Price: 39.99, Change: +0.37, Percent Change: +0.92
J.P. Morgan Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Announces Target Price $69
J.P. Morgan analyst Anupam Rama maintains $IDEAYA Biosciences(IDYA.US)$ with a buy rating, and sets the target price at $69.According to TipRanks data, the analyst has a success rate of 47.0% and a
No Data